All Stories

  1. RNAseq Reveals the Contribution of Interferon Stimulated Genes to the Increased Host Defense and Decreased PPR Viral Replication in Cattle
  2. Comparison of Immunogenicity and Protective Efficacy of PPR Live Attenuated Vaccines (Nigeria 75/1 and Sungri 96) Administered by Intranasal and Subcutaneous Routes
  3. Characterisation of Peste Des Petits Ruminants Disease in Pastoralist Flocks in Ngorongoro District of Northern Tanzania and Bluetongue Virus Co-Infection
  4. Detection of Bovine Antibodies against a Conserved Capsid Epitope as the Basis of a Novel Universal Serological Test for Foot-and-Mouth Disease
  5. Eradication of Peste des Petits Ruminants Virus and the Wildlife-Livestock Interface
  6. Peste des Petits Ruminants at the Wildlife–Livestock Interface in the Northern Albertine Rift and Nile Basin, East Africa
  7. Outbreak of Peste des Petits Ruminants among Critically Endangered Mongolian Saiga and Other Wild Ungulates, Mongolia, 2016–2017
  8. Detection of antibodies against a conserved capsid epitope as the basis of a novel universal serological test for foot-and-mouth disease
  9. Rapid Detection of Peste des Petits Ruminants Virus (PPRV) Nucleic Acid Using a Novel Low-Cost Reverse Transcription Loop-Mediated Isothermal Amplification (RT-LAMP) Assay for Future Use in Nascent PPR Eradication Programme
  10. Identification of novel epitopes in serotype O foot-and-mouth disease virus by in vitro immune selection
  11. Optimization and evaluation of a non-invasive tool for peste des petits ruminants surveillance and control
  12. Quantifying Levels of Peste Des Petits Ruminants (PPR) Virus in Excretions from Experimentally Infected Goats and Its Importance for Nascent PPR Eradication Programme
  13. Molecular characterization of Peste des petits ruminants viruses in the Marmara Region of Turkey
  14. Detection of foot-and-mouth disease virus in milk samples by real-time reverse transcription polymerase chain reaction: Optimisation and evaluation of a high-throughput screening method with potential for disease surveillance
  15. Monoclonal antibody resistant mutant of Peste des petits ruminants vaccine virus
  16. Waves of endemic foot-and-mouth disease in eastern Africa suggest feasibility of proactive vaccination approaches
  17. Foot and mouth disease vaccine strain selection: current approaches and future perspectives
  18. Molecular detection, isolation and characterization of Peste-des-petits ruminants virus from goat milk from outbreaks in Bangladesh and its implication for eradication strategy
  19. Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain
  20. Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007–2012) circulating in Southeast Asia, East Asia and Far East
  21. Persistence of Lineage IV Peste-des-petits ruminants virus within Israel since 1993: An evolutionary perspective
  22. Peste des petits ruminants (PPR): A neglected tropical disease in Maghreb region of North Africa and its threat to Europe
  23. Re-emergence of Peste des Petits Ruminants virus in 2015 in Morocco: Molecular characterization and experimental infection in Alpine goats
  24. Tracking the Antigenic Evolution of Foot-and-Mouth Disease Virus
  25. Emergence of antigenic variants within serotype A FMDV in the Middle East with antigenically critical amino acid substitutions
  26. Spillover of Peste des Petits Ruminants Virus from Domestic to Wild Ruminants in the Serengeti Ecosystem, Tanzania
  27. Peste des petits ruminants
  28. Detection and Genetic Characterization of Lineage IV Peste Des Petits Ruminant Virus in Kazakhstan
  29. Serological Detection of Antibodies to Peste des Petits Ruminants Virus in Large Ruminants
  30. Complete Genome Sequences of Serotype O Foot-and-Mouth Disease Viruses Recovered from Experimental Persistently Infected Cattle
  31. Virus Excretion from Foot-And-Mouth Disease Virus Carrier Cattle and Their Potential Role in Causing New Outbreaks
  32. Prediction and characterization of novel epitopes of serotype A foot-and-mouth disease viruses circulating in East Africa using site-directed mutagenesis
  33. Development of a Competitive Enzyme-Linked Immunosorbent Assay for Detection of Antibodies against the 3B Protein of Foot-and-Mouth Disease Virus
  34. Antigenic and genetic comparison of foot-and-mouth disease virus serotype O Indian vaccine strain, O/IND/R2/75 against currently circulating viruses
  35. Rescue of a vaccine strain of peste des petits ruminants virus: In vivo evaluation and comparison with standard vaccine
  36. Serological profile of foot-and-mouth disease in wildlife populations of West and Central Africa with special reference to Syncerus caffer subspecies
  37. Pathology of Peste des Petits Ruminants
  38. Molecular Epidemiology of Peste des Petits Ruminants Virus
  39. Vaccines Against Peste des Petits Ruminants Virus
  40. Molecular Evolution of Peste des Petits Ruminants Virus
  41. Peste des Petits Ruminants Virus, Eastern Asia
  42. Molecular characterization of peste-des-petits ruminants virus (PPRV) isolated from an outbreak in the Indo-Bangladesh border of Tripura state of North-East India
  43. Emergence of Lineage IV Peste des Petits Ruminants Virus in Ethiopia: Complete Genome Sequence of an Ethiopian Isolate 2010
  44. Toll-Like Receptor Responses to Peste des petits ruminants Virus in Goats and Water Buffalo
  45. Molecular characterisation of lineage IV peste des petits ruminants virus using multi gene sequence data
  46. Complete Genome Sequences of Lineage III Peste des Petits Ruminants Viruses from the Middle East and East Africa
  47. Genetic and antigenic characterisation of serotype A FMD viruses from East Africa to select new vaccine strains
  48. Transmission of foot-and-mouth disease virus from experimentally infected Indian buffalo (Bubalus bubalis) to in-contact naïve and vaccinated Indian buffalo and cattle
  49. Detection of subclinical peste des petits ruminants virus infection in experimental cattle
  50. Morbillivirus vaccines: Recent successes and future hopes
  51. Characteristics of a foot-and-mouth disease virus with a partial VP1 G-H loop deletion in experimentally infected cattle
  52. Patterns of Foot-and-Mouth Disease Virus Distribution in Africa
  53. Evolutionary genetics underlying the spread of peste des petits ruminants virus
  54. Peste des Petits Ruminants Infection among Cattle and Wildlife in Northern Tanzania
  55. Early Events following Experimental Infection with Peste-Des-Petits Ruminants Virus Suggest Immune Cell Targeting
  56. Efficient production of foot-and-mouth disease virus empty capsids in insect cells following down regulation of 3C protease activity
  57. Development and evaluation of a real-time reverse transcription-loop-mediated isothermal amplification assay for rapid serotyping of foot-and-mouth disease virus
  58. Interferon-γ Induced by In Vitro Re-Stimulation of CD4+ T-Cells Correlates with In Vivo FMD Vaccine Induced Protection of Cattle against Disease and Persistent Infection
  59. Complete Genome Sequence of a Peste des Petits Ruminants Virus Recovered from Wild Bharal in Tibet, China
  60. A Reliable and Reproducible Experimental Challenge Model for Peste des Petits Ruminants Virus
  61. A novel approach to generating morbillivirus vaccines: Negatively marking the rinderpest vaccine
  62. Field application of a recombinant protein-based ELISA during the 2010 outbreak of foot-and-mouth disease type A in South Korea
  63. Peste des petits ruminants: a suitable candidate for eradication?
  64. Evaluation of cross-protection between O1 Manisa and O1 Campos in cattle vaccinated with foot-and-mouth disease virus vaccine incorporating different payloads of inactivated O1 Manisa antigen
  65. Molecular Characterisation of Foot-and-Mouth Disease Viruses from Pakistan, 2005-2008
  66. Global distribution of peste des petits ruminants virus and prospects for improved diagnosis and control
  67. Vaccines against peste des petits ruminants virus
  68. Longevity of protection in cattle following immunisation with emergency FMD A22 serotype vaccine from the UK strategic reserve
  69. Strategies for differentiating infection in vaccinated animals (DIVA) for foot-and-mouth disease, classical swine fever and avian influenza
  70. The effect of vaccination on undetected persistence of foot-and-mouth disease virus in cattle herds and sheep flocks
  71. Vaccination against foot-and-mouth disease virus: strategies and effectiveness
  72. Infectious bursal disease subviral particles displaying the foot-and-mouth disease virus major antigenic site
  73. Emergency vaccination of sheep against foot-and-mouth disease: Significance and detection of subsequent sub-clinical infection
  74. Serological Survey for Foot-and-Mouth Disease Virus in Wildlife in Eastern Africa and Estimation of Test Parameters of a Nonstructural Protein Enzyme-Linked Immunosorbent Assay for Buffalo
  75. Further evaluation of higher potency vaccines for early protection of cattle against FMDV direct contact challenge
  76. Reduction of foot-and-mouth disease (FMD) virus load in nasal excretions, saliva and exhaled air of vaccinated pigs following direct contact challenge
  77. Use of a Standardized Bovine Serum Panel To Evaluate a Multiplexed Nonstructural Protein Antibody Assay for Serological Surveillance of Foot-and-Mouth Disease
  78. Rescue of a chimeric rinderpest virus with the nucleocapsid protein derived from peste-des-petits-ruminants virus: use as a marker vaccine
  79. Chimeric tymovirus-like particles displaying foot-and-mouth disease virus non-structural protein epitopes and its use for detection of FMDV-NSP antibodies
  80. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-and-mouth disease virus
  81. Application of non-structural protein antibody tests in substantiating freedom from foot-and-mouth disease virus infection after emergency vaccination of cattle
  82. Matrix protein and glycoproteins F and H of Peste-des-petits-ruminants virus function better as a homologous complex
  83. Importance of the extracellular and cytoplasmic/transmembrane domains of the haemagglutinin protein of rinderpest virus for recovery of viable virus from cDNA copies
  84. Effect of emergency FMD vaccine antigen payload on protection, sub-clinical infection and persistence following direct contact challenge of cattle
  85. Secretory IgA as an indicator of oro-pharyngeal foot-and-mouth disease virus replication and as a tool for post vaccination surveillance
  86. Interferon-γ production in vitro from whole blood of foot-and-mouth disease virus (FMDV) vaccinated and infected cattle after incubation with inactivated FMDV
  87. Utility of automated real-time RT-PCR for the detection of foot-and-mouth disease virus excreted in milk
  88. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease
  89. The Plowright vaccine strain of Rinderpest virus has attenuating mutations in most genes
  90. Protection against direct-contact challenge following emergency FMD vaccination of cattle and the effect on virus excretion from the oropharynx
  91. Sequence analysis of the phosphoprotein gene of peste des petits ruminants (PPR) virus: editing of the gene transcript
  92. Rinderpest virus lineage differentiation using RT-PCR and SNAP-ELISA
  93. Contribution of epidemiological knowledge and control strategies in the eradication of rinderpest virus.